Top Markets
Coin of the day
Nutra Pharma Corp. Nutra Pharma Corp.

Nutra Pharma Corp.

NPHC
Ранг среди акций #38964
Nutra Pharma Corp. (NPHC) operates as a biopharmaceutical firm specializing in... Nutra Pharma Corp. (NPHC) operates as a biopharmaceutical firm specializing in obtaining, licensing, and bringing to market a variety of pharmaceutical products, cutting-edge technologies, and both homeopathic and ethical medications. The company primarily targets the U.S. market, focusing its efforts on managing conditions such as pain, neurological ailments, cancer, autoimmune diseases, and infectious diseases. Its current commercial offerings include: Nyloxin and Nyloxin Extra Strength: These products are distributed as an oral spray for alleviating lower back pain, migraines, neck and shoulder discomfort, cramps, and neuropathic pain, and as a topical gel to relieve joint pain, arthritis, and repetitive stress injuries. Pet Pain-Away: An over-the-counter (OTC) homeopathic, non-narcotic, and non-addictive solution for chronic pain in household pets. Luxury Feet: An OTC pain reliever and anti-inflammatory designed to ease foot pain or discomfort specifically caused by high heels and stilettos. Nyloxin Military Strength: A specialized formulation for pain relief aimed at the United States Military and Veteran's Administration. Equine Pain-Away: An OTC topical pain management product for horses. Beyond its existing portfolio, Nutra Pharma Corp. is also advancing several pipeline candidates: RPI-78M: In development to treat neurological conditions such as multiple sclerosis, adrenomyeloneuropathy, and amyotrophic lateral sclerosis, alongside autoimmune diseases like rheumatoid arthritis and myasthenia gravis. RPI-MN: Under investigation for viral diseases, including human immunodeficiency virus (HIV/AIDS) and herpes, as well as for general antiviral applications. RPI-78: Being developed for applications in pain and arthritis. RPI-70: Also in development for pain relief. Founded in 2000, the company is headquartered in Plantation, Florida.
Цена акции
$0.0001
Последняя синхронизация: 2026-08-13
Рыночная капитализация
$715.97K
Изменение (1 день)
0.00%
Изменение (1 год)
-50.00%
Страна
US
Торговля Nutra Pharma Corp. (NPHC)

Категория

Операционная маржа для Nutra Pharma Corp. (NPHC)
Операционная маржа на 2026 TTM: 0.00%
Согласно последним финансовым отчетам и цене акций Nutra Pharma Corp., текущая операционная маржа (TTM) составляет 0.00%. В конце 2026 она составила 0.00%.
История операционной маржи Nutra Pharma Corp. с 2026 по 2026
Операционная маржа на конец каждого года
Год Операционная маржа Изменить
Недостаточно данных для указанных дат.
Операционная маржа для аналогичных компаний или конкурентов
Компания Операционная маржа Разница в операционной марже Страна
0.00% -
DE
0.00% -
DE
0.00% -
JP
0.00% -
CH
23.18% -
IN
Что такое операционная маржа компании?
Операционная маржа — это ключевой показатель прибыльности компании. Более высокая операционная маржа обычно означает, что компания может продавать свои товары или услуги значительно дороже их себестоимости. Она рассчитывается путем деления прибыли компании на её выручку.